Saratoga, CA, United States of America

Tingting Mo

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Inventor Tingting Mo

Introduction

Tingting Mo is an accomplished inventor based in Saratoga, California. He has made significant contributions to the field of pharmaceutical compounds, holding two patents that showcase his innovative work. His research focuses on developing compounds that have therapeutic applications in treating various diseases.

Latest Patents

Tingting Mo's latest patents include the invention of 6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors. This invention relates to compounds of specific formulas and their application in inhibiting LATS in cell populations. Additionally, he has developed compounds and compositions that act as toll-like receptor 7 agonists, which are used in treating diseases associated with Toll-Like Receptor 7 activity.

Career Highlights

Tingting Mo is currently employed at Novartis AG, where he continues to advance his research in pharmaceutical innovations. His work has the potential to impact the treatment and management of various medical conditions, showcasing his dedication to improving healthcare through scientific discovery.

Collaborations

Tingting has collaborated with notable coworkers, including Yongkai Li and Porino Va, who contribute to his research efforts and innovations in the field.

Conclusion

Tingting Mo's contributions to the field of pharmaceuticals through his patents and research at Novartis AG highlight his role as a significant inventor. His work in developing innovative compounds demonstrates the potential for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…